A vaccine given to pregnant women has been found to reduce hospital admissions in babies caused by respiratory syncytial virus, commonly known as RSV, by as much as 80 percent, according to a new study. The findings represent a significant step forward in protecting newborns from one of the most common causes of serious illness in infants.
The study confirms that the vaccine provides excellent protection for babies against life-threatening chest infections linked to RSV. The research adds to growing scientific confidence that vaccinating mothers during pregnancy is an effective strategy for shielding vulnerable newborns who are too young to receive their own immunisations.
RSV is a highly contagious respiratory virus that affects the lungs and breathing passages. While it typically causes mild cold-like symptoms in older children and adults, it can be extremely dangerous for young babies, leading to serious conditions such as bronchiolitis and pneumonia that often require hospitalisation.
Each year, RSV places enormous pressure on health services, particularly during the winter months when the virus circulates most widely. Babies in their first few months of life are considered the most at-risk group, as their immune systems are not yet developed enough to fight off severe infection without medical intervention.
The maternal vaccine works by prompting the mother's immune system to produce antibodies that are then passed to the baby before birth, offering protection from the earliest days of life. This approach of using pregnancy vaccination to protect newborns has already proven successful with other diseases, including whooping cough and influenza.
Health experts have long sought an effective way to reduce the burden RSV places on families and hospitals alike. An 80 percent reduction in hospital admissions would represent a transformative outcome for infant healthcare and could potentially save many young lives each year.
The findings are expected to inform public health policy in a number of countries currently reviewing their vaccination programmes for pregnant women.
